Evaluation of a point-of-care direct spectrophotometric method for measurement of total serum bilirubin in term and near-term neonates

H. A. Barko, Greg L. Jackson, W. D. Engle

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective: To evaluate point-of-care (POC) measurement of total serum bilirubin (TSB) in the management of neonatal jaundice. Study design: TSB was measured by a POC direct spectrophotometric bilirubin method (Unistat™ (U/TSB)) and a standard diazo clinical laboratory method (Olympus AU640E analyzer (diazo/TSB)). Agreement between U/TSB and diazo/TSB was assessed by correlation coefficient and Bland-Altman analysis. Transcutaneous bilirubin (TcB) was measured using JM-103™ (JM). Results: Correlation between U/TSB and diazo/TSB was 0.99 (n = 120). Maximum difference (U/TSB minus diazo/TSB) was -2.9 mg/dl, and 79% were ±1 mg/dl; the average difference was 0.37±0.70 mg/dl and the average absolute difference was 0.60±0.52 mg/dl. Median time to determine U/TSB was 5 min. Correlation between U/TSB and JM was 0.92 (n = 113). Maximum difference (U/TSB minus JM) was 6.3 mg/dl, and 45% were ±1 mg/dl; the average difference was 0.7± 1.8 mg/dl and the average absolute difference was 1.4 ±1.2 mg/dl. Conclusion: Measurement of TSB using Unistat™ provides excellent agreement with diazo/TSB and rapid turnaround time. This technique may provide reliable POC confirmation of TcB results that are above a screening cutoff value.

Original languageEnglish (US)
Pages (from-to)100-105
Number of pages6
JournalJournal of Perinatology
Volume26
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Point-of-Care Systems
Bilirubin
Serum
Neonatal Jaundice

Keywords

  • Diazo method
  • Neonatal jaundice
  • Transcutaneous bilirubin
  • Unistat™ bilirubinometer

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Pediatrics, Perinatology, and Child Health

Cite this

Evaluation of a point-of-care direct spectrophotometric method for measurement of total serum bilirubin in term and near-term neonates. / Barko, H. A.; Jackson, Greg L.; Engle, W. D.

In: Journal of Perinatology, Vol. 26, No. 2, 02.2006, p. 100-105.

Research output: Contribution to journalArticle

@article{c03fb0490cad476caf56ae35a8ece2e1,
title = "Evaluation of a point-of-care direct spectrophotometric method for measurement of total serum bilirubin in term and near-term neonates",
abstract = "Objective: To evaluate point-of-care (POC) measurement of total serum bilirubin (TSB) in the management of neonatal jaundice. Study design: TSB was measured by a POC direct spectrophotometric bilirubin method (Unistat™ (U/TSB)) and a standard diazo clinical laboratory method (Olympus AU640E analyzer (diazo/TSB)). Agreement between U/TSB and diazo/TSB was assessed by correlation coefficient and Bland-Altman analysis. Transcutaneous bilirubin (TcB) was measured using JM-103™ (JM). Results: Correlation between U/TSB and diazo/TSB was 0.99 (n = 120). Maximum difference (U/TSB minus diazo/TSB) was -2.9 mg/dl, and 79{\%} were ±1 mg/dl; the average difference was 0.37±0.70 mg/dl and the average absolute difference was 0.60±0.52 mg/dl. Median time to determine U/TSB was 5 min. Correlation between U/TSB and JM was 0.92 (n = 113). Maximum difference (U/TSB minus JM) was 6.3 mg/dl, and 45{\%} were ±1 mg/dl; the average difference was 0.7± 1.8 mg/dl and the average absolute difference was 1.4 ±1.2 mg/dl. Conclusion: Measurement of TSB using Unistat™ provides excellent agreement with diazo/TSB and rapid turnaround time. This technique may provide reliable POC confirmation of TcB results that are above a screening cutoff value.",
keywords = "Diazo method, Neonatal jaundice, Transcutaneous bilirubin, Unistat™ bilirubinometer",
author = "Barko, {H. A.} and Jackson, {Greg L.} and Engle, {W. D.}",
year = "2006",
month = "2",
doi = "10.1038/sj.jp.7211436",
language = "English (US)",
volume = "26",
pages = "100--105",
journal = "Journal of Perinatology",
issn = "0743-8346",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - Evaluation of a point-of-care direct spectrophotometric method for measurement of total serum bilirubin in term and near-term neonates

AU - Barko, H. A.

AU - Jackson, Greg L.

AU - Engle, W. D.

PY - 2006/2

Y1 - 2006/2

N2 - Objective: To evaluate point-of-care (POC) measurement of total serum bilirubin (TSB) in the management of neonatal jaundice. Study design: TSB was measured by a POC direct spectrophotometric bilirubin method (Unistat™ (U/TSB)) and a standard diazo clinical laboratory method (Olympus AU640E analyzer (diazo/TSB)). Agreement between U/TSB and diazo/TSB was assessed by correlation coefficient and Bland-Altman analysis. Transcutaneous bilirubin (TcB) was measured using JM-103™ (JM). Results: Correlation between U/TSB and diazo/TSB was 0.99 (n = 120). Maximum difference (U/TSB minus diazo/TSB) was -2.9 mg/dl, and 79% were ±1 mg/dl; the average difference was 0.37±0.70 mg/dl and the average absolute difference was 0.60±0.52 mg/dl. Median time to determine U/TSB was 5 min. Correlation between U/TSB and JM was 0.92 (n = 113). Maximum difference (U/TSB minus JM) was 6.3 mg/dl, and 45% were ±1 mg/dl; the average difference was 0.7± 1.8 mg/dl and the average absolute difference was 1.4 ±1.2 mg/dl. Conclusion: Measurement of TSB using Unistat™ provides excellent agreement with diazo/TSB and rapid turnaround time. This technique may provide reliable POC confirmation of TcB results that are above a screening cutoff value.

AB - Objective: To evaluate point-of-care (POC) measurement of total serum bilirubin (TSB) in the management of neonatal jaundice. Study design: TSB was measured by a POC direct spectrophotometric bilirubin method (Unistat™ (U/TSB)) and a standard diazo clinical laboratory method (Olympus AU640E analyzer (diazo/TSB)). Agreement between U/TSB and diazo/TSB was assessed by correlation coefficient and Bland-Altman analysis. Transcutaneous bilirubin (TcB) was measured using JM-103™ (JM). Results: Correlation between U/TSB and diazo/TSB was 0.99 (n = 120). Maximum difference (U/TSB minus diazo/TSB) was -2.9 mg/dl, and 79% were ±1 mg/dl; the average difference was 0.37±0.70 mg/dl and the average absolute difference was 0.60±0.52 mg/dl. Median time to determine U/TSB was 5 min. Correlation between U/TSB and JM was 0.92 (n = 113). Maximum difference (U/TSB minus JM) was 6.3 mg/dl, and 45% were ±1 mg/dl; the average difference was 0.7± 1.8 mg/dl and the average absolute difference was 1.4 ±1.2 mg/dl. Conclusion: Measurement of TSB using Unistat™ provides excellent agreement with diazo/TSB and rapid turnaround time. This technique may provide reliable POC confirmation of TcB results that are above a screening cutoff value.

KW - Diazo method

KW - Neonatal jaundice

KW - Transcutaneous bilirubin

KW - Unistat™ bilirubinometer

UR - http://www.scopus.com/inward/record.url?scp=33646113858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646113858&partnerID=8YFLogxK

U2 - 10.1038/sj.jp.7211436

DO - 10.1038/sj.jp.7211436

M3 - Article

C2 - 16407962

AN - SCOPUS:33646113858

VL - 26

SP - 100

EP - 105

JO - Journal of Perinatology

JF - Journal of Perinatology

SN - 0743-8346

IS - 2

ER -